PeptSense
Create account

Peptide research

Survodutide — compounding legality overview

Survodutide is tracked in the PeptSense formulary. Federal 503A Bulks List chain steps, PCAC advisory context, and state board positions determine whether pharmacies and clinics can compound or offer it — with citations and effective dates.

Survodutide regulatory status

Common names: BI 456906

PeptSense tracks Survodutide across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.

Federal 503A snapshot (illustrative)

Latest published federal event for 503A compounding pharmacies. Sign in for your licensed states and facility type.

Unclear
Summary
Honest expansion baseline (2026-08-12): no confident Bulks List / USP / approved-component chain step assigned for Survodutide in this pass. Unclear until substance-specific citation is curated. Not a legal determination.
Citation
FDA — 503A bulk drug substances page
Effective
Aug. 12, 2026

Not a legal determination. Replace placeholder citations during curation.

Run a full lookup

Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.

Create account View pricing

Related research topics

  • Survodutide legality
  • Survodutide compounding

← All peptides · Resources hub